STEFANIE ROLLINS: Open Payments
NPI 1467780874 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,923 in 48 payments from 14 companies in 2025. Trend: 2023 $2,957 · 2024 $3,275 · 2025 $2,923
Food & beverage: $1,860Consulting: $1,055Education: $8
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $1,159 |
| AstraZeneca Pharmaceuticals LP | 10 | $631 |
| Genentech, Inc. | 2 | $283 |
| GENZYME CORPORATION | 9 | $277 |
| GlaxoSmithKline, LLC. | 6 | $199 |
| Genentech USA, Inc. | 2 | $117 |
| Optinose US, Inc. | 4 | $88 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: DUPIXENT, Xolair, TEZSPIRE, NUCALA, FASENRA, WAYRILZ, Xhance, NEFFY.
Industry payments across OK — which companies pay providers there.
